Evlabio
evlabio.com
Actively hiring
Biologics & Biosimilars
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
11-50
employees, estimated range
Backers
1
Kurma Partners
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Kurma Partners Similar startupsby what they do, their industry and backers
A new path forpatients with Chronic Kidney Disease. At Pathalys Pharma, Inc. we are committed to improving the lives of patients through…
THE CLAUDIN-1 COMPANY Treat cancer and reverse fibrosis We are a clinical-stage biotech company with a mission to treat cancer and reverse…
Our mission is to improve the quality of life of patients with myocardial infarction (MI) and heart failure by providing novel…
Angiex is developing first-in-class Nuclear-Delivered Antibody-Drug Conjugates™ (ND-ADCs) to address the hallmarks of cancer lethality.
Antiverse combines generative AI and advanced antibody discovery to design functional, developable biologics for challenging drug targets.
PathoQuest provides biosafety assays based on next-generation sequencing (NGS) for biologics quality testing. GMP biotesting for…
Overview
Creating innovative therapies for chronic kidney disease patients. Addressing left ventricular hypertrophy with monoclonal antibody treatments.